The Indian pharmaceutical industry, in the medium term, can also look forward to another $ 15-20 billion opportunity in drug discovery research chain after new regime was implemented.
According to Venkat Jasti, president of Bulk Drug Manufacturers Association, Indian companies must gear themselves up in next few years so that they could corner a big chunk of this opportunity.
